MAPK15 and lung neuroendocrine neoplasm: Our findings in the tumoral tissues, as well as the in vitro experiments with ZKK multi-kinase inhibitors, suggest that inhibition of IGF1R and MAPK15 could also be potentially effective in lung NET treatment.